PPARGC1A and liver cancer: Additionally, the p53 pathway can reduce the expression of PGC-1α, which suppresses mitochondrial biogenesis and oxidative phosphorylation by inhibiting the expression of downstream TFAM and p53R2, thus eventually decreasing the proliferation of liver cancer cells (135).